Clinical trial
Single Dose Pharmacokinetic Study of Abacavir in HIV-Infected Children and Adolescents
NCT00011479 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Dose Pharmacokinetic Study of Abacavir in HIV-Infected Children and Adolescents
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- August 31, 2002
- Enrollment
- 24
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.